Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations

Slide collection

230,881-230,910 of 319,975

filter-aware
19
The slide uses a process-flow style diagram to map delivery mechanisms to therapeutic areas.Matinas BioPharma | Investor Presentation Deck | 29 slides · Matinas BioPharma
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
20
The chart shows a clear time-dependent increase in cellular uptake across four cell types (Neutrophils, Monocytes, mDC, pDC).Matinas BioPharma | Investor Presentation Deck | 29 slides · Matinas BioPharma
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
21
Data shows dose-dependent or treatment-specific reduction in disease markers compared to IMQ-only control.Matinas BioPharma | Investor Presentation Deck | 29 slides · Matinas BioPharma
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
22
Includes a line chart for disease activity index over 14 days and two bar charts for TNFa tissue mRNA and serum TNFa levels at day 14.Matinas BioPharma | Investor Presentation Deck | 29 slides · Matinas BioPharma
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
23
Uses a before-after-framing style to contrast healthy vs tumor cell interaction.Matinas BioPharma | Investor Presentation Deck | 29 slides · Matinas BioPharma
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
24
The slide includes a timeline of the study and a legend for the treatment groups.Matinas BioPharma | Investor Presentation Deck | 29 slides · Matinas BioPharma
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
25
The slide uses a line chart to show weight loss over 22 days, highlighting that IV-Docetaxel causes significant weight loss (toxicity) while oral LNC-Docetaxel maintains weight similar to control.Matinas BioPharma | Investor Presentation Deck | 29 slides · Matinas BioPharma
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
26
The slide uses a two-column layout to contrast oncology and inflammation results, followed by a summary box of platform capabilities.Matinas BioPharma | Investor Presentation Deck | 29 slides · Matinas BioPharma
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
27
The slide uses a three-column icon-based layout to summarize IP and regulatory assets.Matinas BioPharma | Investor Presentation Deck | 29 slides · Matinas BioPharma
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
28
Matinas BioPharma | Investor Presentation Deck | 29 slidesMatinas BioPharma | Investor Presentation Deck | 29 slides · Matinas BioPharma
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
29
The slide combines a financial summary with a timeline of milestones and a strategic outlook.Matinas BioPharma | Investor Presentation Deck | 29 slides · Matinas BioPharma
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
01
Slide 1
Includes company logo, ticker symbol, and date.OmniAb | Results Presentation Deck | 24 slides · OmniAb
Conference presentation Investor relations Beat · Attention1 hit
02
OmniAb | Results Presentation Deck | 24 slidesOmniAb | Results Presentation Deck | 24 slides · OmniAb
Conference presentation Investor relations Beat · Attention1 hit
03
OmniAb | Results Presentation Deck | 24 slidesOmniAb | Results Presentation Deck | 24 slides · OmniAb
Conference presentation Investor relations Beat · Attention1 hit
04
OmniAb | Results Presentation Deck | 24 slidesOmniAb | Results Presentation Deck | 24 slides · OmniAb
Conference presentation Investor relations Beat · NeedLoop · Quick Win Big Bet1 hit
05
The slide uses three bar charts to visualize growth metrics.OmniAb | Results Presentation Deck | 24 slides · OmniAb
Conference presentation Investor relations Beat · NeedLoop · Quick Win Big Bet1 hit
06
The pie chart is connected to the 2023 bar via dotted lines, indicating it represents the composition of that specific year's total.OmniAb | Results Presentation Deck | 24 slides · OmniAb
Conference presentation Investor relations Beat · SatisfactionLoop · Quick Win Big Bet1 hit
07
The pie chart represents a total of 10 deals (n=10).OmniAb | Results Presentation Deck | 24 slides · OmniAb
Conference presentation Investor relations Beat · SatisfactionLoop · Quick Win Big Bet1 hit
08
The slide highlights net growth and specific transitions between development stages during 2023.OmniAb | Results Presentation Deck | 24 slides · OmniAb
Conference presentation Investor relations Beat · SatisfactionLoop · Quick Win Big Bet1 hit
09
The slide highlights the company's pipeline growth and provides specific examples of partner programs.OmniAb | Results Presentation Deck | 24 slides · OmniAb
Conference presentation Investor relations Beat · SatisfactionLoop · Quick Win Big Bet1 hit
10
The slide uses a process-oriented framework to categorize various proprietary technologies.OmniAb | Results Presentation Deck | 24 slides · OmniAb
Conference presentation Investor relations Beat · SatisfactionLoop · Quick Win Big Bet1 hit
11
OmniAb | Results Presentation Deck | 24 slidesOmniAb | Results Presentation Deck | 24 slides · OmniAb
Conference presentation Investor relations Loop · Quick Win Big Bet1 hit
12
The slide explains the derivation of sdAb from HcAb, highlighting the reduction in molecular weight and structural complexity.OmniAb | Results Presentation Deck | 24 slides · OmniAb
Conference presentation Investor relations Loop · Quick Win Big Bet1 hit
13
The slide uses a list-based layout to highlight the versatility of sdAbs in administration, tissue penetration, diagnostics, and therapeutics.OmniAb | Results Presentation Deck | 24 slides · OmniAb
Conference presentation Investor relations Loop · Quick Win Big Bet1 hit
14
The slide uses a list-based layout with icons to highlight three strategic pillars.OmniAb | Results Presentation Deck | 24 slides · OmniAb
Conference presentation Investor relations Beat · ActionLoop · Quick Win Big Bet1 hit
15
OmniAb | Results Presentation Deck | 24 slidesOmniAb | Results Presentation Deck | 24 slides · OmniAb
Conference presentation Investor relations Beat · Action1 hit
16
The table includes a disclaimer about rounded figures and a reference to the press release dated 3/20/2024.OmniAb | Results Presentation Deck | 24 slides · OmniAb
Conference presentation Investor relations Beat · Action1 hit
17
The table includes a variance column and per-share data.OmniAb | Results Presentation Deck | 24 slides · OmniAb
Conference presentation Investor relations Beat · Action1 hit
18
The table includes Q1-Q4 and full-year FY 23 data. The right-hand text provides guidance on 2024 operating expenses.OmniAb | Results Presentation Deck | 24 slides · OmniAb
Conference presentation Investor relations Beat · Action1 hit
19
Includes a disclaimer about rounded figures and a reference to the press release dated 3/20/2024.OmniAb | Results Presentation Deck | 24 slides · OmniAb
Conference presentation Investor relations Beat · Action1 hit